Now out of business, NeuroTherapeutics Pharma, Inc. (NTP) was a biopharmaceutical company focused on developing therapies for diseases associated with central nervous system hyper-excitability. The company was working with novel mechanisms that would generate first-in-class therapeutics, thereby changing the standard of care for patients suffering from epilepsy, neuropathic and acute pain, and other disorders of the nervous system.
